5-140114310-TGGCGGCGGC-TGGC
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_005859.5(PURA):c.141_146delCGGCGG(p.Gly48_Gly49del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,290,974 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000087 ( 0 hom. )
Consequence
PURA
NM_005859.5 disruptive_inframe_deletion
NM_005859.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.31
Genes affected
PURA (HGNC:9701): (purine rich element binding protein A) This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of this gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 5-140114310-TGGCGGC-T is Benign according to our data. Variant chr5-140114310-TGGCGGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 624066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PURA | NM_005859.5 | c.141_146delCGGCGG | p.Gly48_Gly49del | disruptive_inframe_deletion | 1/1 | ENST00000331327.5 | NP_005850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PURA | ENST00000331327.5 | c.141_146delCGGCGG | p.Gly48_Gly49del | disruptive_inframe_deletion | 1/1 | 6 | NM_005859.5 | ENSP00000332706.3 | ||
PURA | ENST00000651386.1 | c.141_146delCGGCGG | p.Gly48_Gly49del | disruptive_inframe_deletion | 2/2 | ENSP00000499133.1 | ||||
PURA | ENST00000505703.2 | c.141_146delCGGCGG | p.Gly48_Gly49del | disruptive_inframe_deletion | 2/2 | 3 | ENSP00000498560.1 |
Frequencies
GnomAD3 genomes AF: 0.0000215 AC: 3AN: 139488Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
139488
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000868 AC: 10AN: 1151486Hom.: 0 AF XY: 0.0000107 AC XY: 6AN XY: 558764
GnomAD4 exome
AF:
AC:
10
AN:
1151486
Hom.:
AF XY:
AC XY:
6
AN XY:
558764
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000215 AC: 3AN: 139488Hom.: 0 Cov.: 32 AF XY: 0.0000148 AC XY: 1AN XY: 67752
GnomAD4 genome
AF:
AC:
3
AN:
139488
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
67752
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2021 | Has not been previously published as pathogenic or benign to our knowledge; In-frame deletion of 2 amino acids in a repetitive region with no known function - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | PURA: BP3 - |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at